Atlas Trials

Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes

Clinical trial NCT05446532 · COMPLETED

Trial details

NCT number
NCT05446532
Sponsor
Corporacion Parc Tauli
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatitis B
Start date
2022-06-15
Primary completion
2022-10-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.